Liaoning He Eye Hospital Group Co. LTD. Market Cap ($359.12 Million)
Market Cap & Net Worth: Liaoning He Eye Hospital Group Co. LTD. (301103)
Liaoning He Eye Hospital Group Co. LTD. market cap. Liaoning He Eye Hospital Group Co. LTD. (SHE:301103) has a market capitalization of $359.12 Million (CN¥2.45 Billion) as of November 4, 2026. Listed on the SHE stock exchange, this China-based company holds position #13624 globally and #4000 in its home market, demonstrating a -3.00% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Liaoning He Eye Hospital Group Co. LTD.'s stock price CN¥15.53 by its total outstanding shares 158026471 (158.03 Million). Also see 301103 cash flow conversion for how efficiently the company converts equity into cash flow.
Liaoning He Eye Hospital Group Co. LTD. Market Cap History (2022–2026)
Liaoning He Eye Hospital Group Co. LTD. market cap history from 2022 to 2026. Data shows change from $692.28 Million to $359.12 Million (-16.38% CAGR). Check today's stock price for Liaoning He Eye Hospital Group Co. LTD. for real-time trading data and today's change.
Liaoning He Eye Hospital Group Co. LTD. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Liaoning He Eye Hospital Group Co. LTD.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Liaoning He Eye Hospital Group Co. LTD. annual equity growth to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.42x
Liaoning He Eye Hospital Group Co. LTD.'s market cap is 0.42 times its annual revenue
Latest Price to Earnings (P/E) Ratio
16.60x
Liaoning He Eye Hospital Group Co. LTD.'s market cap is 16.60 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $692.28 Million | $955.31 Million | $32.59 Million | 0.72x | 21.24x |
| 2023 | $673.91 Million | $1.19 Billion | $63.55 Million | 0.57x | 10.60x |
| 2024 | $465.26 Million | $1.10 Billion | -$27.40 Million | 0.42x | N/A |
| 2025 | $453.70 Million | $1.09 Billion | $27.34 Million | 0.42x | 16.60x |
Competitor Companies of 301103 by Market Capitalization
Companies near Liaoning He Eye Hospital Group Co. LTD. in the global market cap rankings as of November 4, 2026. Also see 301103 total assets for a full breakdown of the balance sheet.
Key companies related to Liaoning He Eye Hospital Group Co. LTD. by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #283 globally with a market cap of $91.34 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #903 globally with a market cap of $29.19 Billion USD ( €24.97 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #985 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- Tenet Healthcare Corporation (NYSE:THC): Ranked #1213 globally with a market cap of $20.93 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #283 | HCA Healthcare, Inc. | NYSE:HCA | $91.34 Billion | $462.86 |
| #903 | Fresenius SE & Co. KGaA | XETRA:FRE | $29.19 Billion | €48.81 |
| #985 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1213 | Tenet Healthcare Corporation | NYSE:THC | $20.93 Billion | $266.69 |
Market Capitalization of Liaoning He Eye Hospital Group Co. LTD. (2022–2026)
Market capitalization of Liaoning He Eye Hospital Group Co. LTD. from 2022 to today. Between 2022 and today, Liaoning He Eye Hospital Group Co. LTD.'s market cap moved from $692.28 Million to $ 359.12 Million, with a yearly change of -16.38%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥359.12 Million | -20.85% |
| 2025 | CN¥453.70 Million | -2.49% |
| 2024 | CN¥465.26 Million | -30.96% |
| 2023 | CN¥673.91 Million | -2.65% |
| 2022 | CN¥692.28 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of Liaoning He Eye Hospital Group Co. LTD. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $359.12 Million USD |
| MoneyControl | $359.12 Million USD |
| MarketWatch | $359.12 Million USD |
| marketcap.company | $359.12 Million USD |
| Reuters | $359.12 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Liaoning He Eye Hospital Group Co. LTD.
Liaoning He Eye Hospital Group Co., LTD., together with its subsidiaries, provides ophthalmological and optometry services to patients with eye diseases in China. The company offers treatment for common blinding eye diseases, including cataracts, glaucoma, and vitreoretinal disorders; specialized treatments, such as dry eye and traditional Chinese medicine; and optometry services, including optic… Read more